XSHG
605016
, Last price
Name
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. specializes in the manufacturing and global distribution of functional carbohydrates. The company's diverse product range includes various categories: Oligosaccharides: Offered in both powdered and liquid forms, such as oligofructose, isomalto oligosaccharide, xylo-oligosaccharides, and galactooligosaccharides. Dietary Fibers: Featuring ingredients like polydextrose and resistant dextrin. Sugar Alcohols: Encompassing crystalline maltitol and maltitol syrup. Starch Sugars: Including high fructose syrup, maltodextrin, and high maltose powder. Specialty Syrups: Formulations tailored for applications like mono cake, bakery, and bread products. Fermentation Products: A separate category of offerings. Established in 2005, the enterprise maintains its headquarters in Yucheng, China.
Headquarters & legal address
山东省德州(禹城)国家高新技术产业开发区德信大街
德州市, SD 251200
CN
德州市, SD 251200
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||